Conmed Corp’s filing revealed that its Director Farkas Charles unloaded Company’s shares for reported $0.11 million on Sep 12 ’25. In the deal valued at $53.52 per share,2,000 shares were sold. As a result of this transaction, Farkas Charles now holds 14,859 shares worth roughly $0.74 million.
Then, Farkas Charles bought 2,000 shares, generating $107,049 in total proceeds.
Before that, Garner Todd W sold 598 shares. Conmed Corp shares valued at $31,365 were divested by the Executive Vice President & CFO at a price of $52.45 per share. As a result of the transaction, Garner Todd W now holds 0 shares, worth roughly $0.0.
Needham downgraded its Conmed Corp [CNMD] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in late April from “a Buy” to “a Hold”. JP Morgan also remained covering CNMD and has decreased its forecast on February 06, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. Needham maintained its rating on February 01, 2024. It rated CNMD as “a Buy”.
Price Performance Review of CNMD
On Friday, Conmed Corp [NYSE:CNMD] saw its stock fall -2.74% to $50.01. Over the last five days, the stock has lost -5.46%. Conmed Corp shares have fallen nearly -33.14% since the year began. Nevertheless, the stocks have fallen -26.93% over the past one year.
How much short interest is there in Conmed Corp?
A steep rise in short interest was recorded in Conmed Corp stocks on 2025-08-29, dropping by 6436.0 shares to a total of 2.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 2.1 million shares. There was a decline of -0.31%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 22, 2023 when CL King began covering the stock and recommended ‘”a Buy”‘ rating along with a $140 price target.
